SmithKline climbs 2% on earnings

Article Abstract:

SmithKline Beecham PLC saw its share value rise by 2% as a result of its 16% rise in pretax profits for the first quarter of 1999. The company posted 510 million pound sterling ($822 million) in profits for the period. This is compared to 440 million pound sterling during the same period in 1998. Analysts had predicted SmithKline would post between 480 million pound sterling and 506 million pound sterling.

Comment:

Posts 16% rise in 1999 first quarter pretax profits

United Kingdom, SmithKline Beecham PLC

---

Roche's group sales rose by 4% in the first quarter

Article Abstract:

Roche Holding AG posted an improvement of 4% in group sales for the first quarter of 1999. Roche's sales rose to 6.41 billion Swiss francs ($4.32 billion) for the quarter. During the same period in 1998, the pharmaceutical firm posted sales of 6.18 billion francs. Roche also said that its key drug unit reported an 8% rise in sales that were totaled in Swiss francs.

Comment:

Posts improvement of 4% in group sales for first quarter of 1999

Switzerland, Roche Holding AG

---

Innogenetic's loss widened to 9.3 million euros in quarter

Article Abstract:

Innogenetics NV posted a higher net loss of 9.3 million euros for the 1999 second-quarter. The company posted a 2.3 million euros net loss for the same period in 1998.

Belgium, Drugs, Innogenetics N.V./S.A.

Similar abstracts:

• Abstracts: OTC medicines, cosmetics and personal care products in France. Chemists' goods in Germany
• Abstracts: Global One chief resigns, clouding venture's future. Mohn gives up control of Bertelsmann
• Abstracts: Howard's way. Fleuriet quits Merrill for HSBC
• Abstracts: Can media kill? One voice or many? La regle du jeu: French-inspired plans to protect Europe's film industry are extremely silly

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.